SPDR S&P Pharmaceuticals ETF (XPH) ETF
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 247.70M |
| Net Asset Value (NAV) | $40.94 |
| Options? | Yes |
| Total Holdings | 48 |
XPH Stock Chart More Charts
XPH Price/Volume Stats
| Current price | $41.70 |
| Prev. close | $41.27 |
| Day low | $41.47 |
| Day high | $41.75 |
| 50-day MA | $39.38 |
| 200-day MA | $43.62 |
| 52-week high | $49.97 |
| 52-week low | $34.51 |
| Volume | 19,000 |
| Avg. volume | 69,181 |
| Dividend yield | 0.58% |
XPH Top Holdings
| Symbol | Company | % of Total |
| NKTR | Nektar Therapeutics | 5.11% |
| MNK | Mallinckrodt Plc | 4.97% |
| MYL | Mylan N.V. | 4.75% |
| LLY | Eli Lilly and Company | 4.73% |
| ZTS | Zoetis Inc. Class A | 4.62% |
| ENDP | Endo International Plc | 4.52% |
| MRK | Merck & Co. Inc. | 4.52% |
| JNJ | Johnson & Johnson | 4.42% |
| BMY | Bristol-Myers Squibb Company | 4.27% |
| PFE | Pfizer Inc. | 4.2% |
XPH Returns
| 1-mo | 3.63% |
| 3-mo | -1.70% |
| 6-mo | -14.23% |
| 1-year | -3.59% |
| 3-year | 0.90% |
| 5-year | -9.73% |
| YTD | 13.87% |
| 2018 | -15.32% |
| 2017 | 12.05% |
| 2016 | -23.20% |
| 2015 | -4.62% |
| 2014 | 29.52% |
XPH Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||